Zyla Life Sciences - FORM 10-K - EX-21.1 - March 16, 2015

Attached files

file filename
EX-2.1 - EX-2.1 - Zyla Life Sciencesa2223665zex-2_1.htm
EX-10.2 - EX-10.2 - Zyla Life Sciencesa2223665zex-10_2.htm
EX-32.1 - EX-32.1 - Zyla Life Sciencesa2223665zex-32_1.htm
EX-32.2 - EX-32.2 - Zyla Life Sciencesa2223665zex-32_2.htm
EX-10.4 - EX-10.4 - Zyla Life Sciencesa2223665zex-10_4.htm
EX-23.1 - EX-23.1 - Zyla Life Sciencesa2223665zex-23_1.htm
EX-31.1 - EX-31.1 - Zyla Life Sciencesa2223665zex-31_1.htm
EX-10.1 - EX-10.1 - Zyla Life Sciencesa2223665zex-10_1.htm
EX-10.3 - EX-10.3 - Zyla Life Sciencesa2223665zex-10_3.htm
EX-31.2 - EX-31.2 - Zyla Life Sciencesa2223665zex-31_2.htm
EXCEL - IDEA: XBRL DOCUMENT - Zyla Life SciencesFinancial_Report.xls
10-K - 10-K - Zyla Life Sciencesa2223665z10-k.htm
EX-4.2 - EX-4.2 - Zyla Life Sciencesa2223665zex-4_2.htm

QuickLinks -- Click here to rapidly navigate through this document


Exhibit 21.1

        Set forth below are the names of the Company's subsidiaries, each 100% owned, directly or indirectly, as of December 31, 2014.

Subsidiary
  Jurisdiction of
Incorporation
Egalet Limited   United Kingdom
Egalet US Inc.    Delaware



QuickLinks

Zyla Life Sciences Reports